Earnings Call · Q2 FY2023·2023-08-08

Q2 23EPS -27.27%·Rev n/aQ1 23EPS +33.33%·Rev n/aQ4 22EPS +33.33%·Rev n/aQ3 22EPS -100.00%*·Rev n/a⚠ consensus missing

HARVARD BIOSCIENCE INC HBIO

Dave Sirois — Director of SEC Reporting

James Green — President and CEO

Jennifer Cote — Chief Financial Officer

−2.0%1d on move date−1.6% vs SPY3d−6.4%5d−11.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HBIO calls or request research access.

More HBIO calls Browse calls Request research access